50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today CYCC ranks #12120 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Cyclacel Pharmaceuticals Stock Forecast NASDAQ:CYCC

$3.85 (0.26%)

Volume: 31k

Closed: Nov 26, 2021

Hollow Logo Score: -4.515

Cyclacel Pharmaceuticals Stock Forecast

$3.85 (0.26%)

Volume: 31k

Closed: Nov 26, 2021

Score Hollow Logo -4.515
Which way will CYCC go? Request
Key Stats
Beta 1.73
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] The Cyclacel Pharmaceuticals stock currently holds an RSI14 at 19 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Cyclacel Pharmaceuticals stock price ended on $3.85 on Friday after gaining 0.26%
(Updated on Nov 26, 2021)

Sell candidate since 2021-11-15 Loss -19.46%

The Cyclacel Pharmaceuticals stock price gained 0.26% on the last trading day (Friday, 26th Nov 2021), rising from $3.84 to $3.85. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 4.71% from a day low at $3.72 to a day high of $3.90. The price has fallen in 8 of the last 10 days and is down by -23.76% for this period. Volume fell on the last day by -38 thousand shares and in total, 31 thousand shares were bought and sold for approximately $120.91 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.72 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -21.54% during the next 3 months and, with a 90% probability hold a price between $2.92 and $3.96 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, November 23, 2021, and so far it has risen 2.39%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cyclacel Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.08 and $4.92. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss

Cyclacel Pharmaceuticals finds support from accumulated volume at $3.84 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.18 between high and low, or 4.71%. For the last week the stock has had a daily average volatility of 6.06%.

Cyclacel Pharmaceuticals is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Cyclacel Pharmaceuticals stock A Buy?

Cyclacel Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.515

Predicted Opening Price for Cyclacel Pharmaceuticals of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$3.82 $3.85 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 18, 2021 "LADENBURG THALM/SH SH" gave "$18.00 - $17.00" rating for CYCC. The price target was changed from $4.62 to 1.1%.

Volatility and Risk
Daily Average Volatility: 6.06 %
Overall Risk: Very High High Medium Low Very Low
6.06 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $3.93
Price: $3.85
Support: $3.84

CYCC Insider Trading Show all Trades



Last 100 transactions
Buy: 4 530 461 | Sell: 7 003 (Shares)
Date Action Amount Person Type
Nov 18, 2021 Buy 4 000 Rombotis Spiro George Common Stock
Aug 24, 2021 Buy 1 000 Barker Sam L Common Stock
Jun 15, 2021 Buy 2 374 Schwartz Brian Stock Option (right to buy)
Jun 15, 2021 Buy 1 187 Schwartz Brian Common Stock
Jun 15, 2021 Buy 2 374 Walker Karin L Stock Option (right to buy)
Show all Insider Trades


Last 100 transactions
Buy: 4 530 461 | Sell: 7 003 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 4.00 3.90 %
3.93 2.16 %
3.89 1.09 %
Current price: 3.85
Support 3.76 -2.40 %
3.72 -3.47 %
3.65 -5.21 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 4.28 11.17 %
4.21 9.35 %
3.93 2.08 %
Current price 3.85
Support 3.84 -0.26%
3.76 -2.34%
0 .

Click to get the best stock tips daily for free!

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE